34 related articles for article (PubMed ID: 2649378)
1. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.
Cornelissen JJ; Gratwohl A; Schlenk RF; Sierra J; Bornhäuser M; Juliusson G; Råcil Z; Rowe JM; Russell N; Mohty M; Löwenberg B; Socié G; Niederwieser D; Ossenkoppele GJ
Nat Rev Clin Oncol; 2012 Oct; 9(10):579-90. PubMed ID: 22949046
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation using unrelated donors for haematological malignancies.
Ringdén O
Med Oncol; 1997 Mar; 14(1):11-22. PubMed ID: 9232606
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia.
Willemze R; Fibbe WE; Kluin-Nelemans JC; Falkenburg JH; Richel DJ; Peters WG; den Ottolander GJ; Brand A; Zwaan FE
Ann Hematol; 1991; 62(2-3):59-63. PubMed ID: 2031969
[TBL] [Abstract][Full Text] [Related]
4. The value of BMT in AML patients in first remission. A statistician's view-point.
Suciu S
Ann Hematol; 1991; 62(2-3):41-4. PubMed ID: 2031967
[No Abstract] [Full Text] [Related]
5. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
[No Abstract] [Full Text] [Related]
7. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
[TBL] [Abstract][Full Text] [Related]
8. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
[No Abstract] [Full Text] [Related]
10. Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation.
Hermans J; Suciu S; Stijnen T; Aegerter P; Gorin NC; Gratwohl A; Hayat M; Stryckmans P; Zittoun R; Zwaan FE
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):545-50. PubMed ID: 2649378
[TBL] [Abstract][Full Text] [Related]
11. Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
Sica S; Di Mario A; Pagano L; Etuk B; Salutari P; Leone G
Acta Haematol; 1992; 87(4):173-5. PubMed ID: 1519431
[TBL] [Abstract][Full Text] [Related]
12. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
